Lisanne E. Nijman

Lisanne E. Nijman

Auto-generated profile, based on publicly available information

Lisanne E. Nijman

Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2018 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
KLKristiaan J. Lenos
Kristiaan J. Lenos
DMDaniël M. Miedema
Daniël M. Miedema
SLSophie C. Lodestijn
Sophie C. Lodestijn
LNLisanne E. Nijman
Lisanne E. Nijman
TBTom van Den Bosch
Tom van Den Bosch
LVLouis Vermeulen
Louis Vermeulen

8 March 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MHMaartje van der Heijden
Maartje van der Heijden
DMDaniël M. Miedema
Daniël M. Miedema
BWBartlomiej Waclaw
Bartlomiej Waclaw
VVVeronique L. Veenstra
Veronique L. Veenstra
MLMaria C. Lecca
Maria C. Lecca
LVLouis Vermeulen
Louis Vermeulen
Significance: Colorectal cancer (CRC) is a heterogeneous disease, with significant variation in genotype and phenotype within each individual tumor. This intratumor heterogeneity emerges during tumor development due to clonal evolution and in part can explain therapy resistance in CRC. However, a detailed understanding of the spatiotemporal development of tumors underlying cancer evolution and intratumor heterogeneity remains absent. Here, we use lineage-tracing experiments of human CRC cells transplanted into immunocompromised mice, in combination with computational modeling, to study the growth mode of CRC. We found that the clonal position is crucial for clonal outgrowth. This demonstrates that, in addition to the genetic composition, the environment and the geometry of tumor growth play a significant role in shaping tumor evolution.

1 November 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
VBVivian P. Bastiaenen
Vivian P. Bastiaenen
CKCharlotte E. L. Klaver
Charlotte E. L. Klaver
MHMaartje C. S. van der Heijden
Maartje C. S. van der Heijden
LNLisanne E. Nijman
Lisanne E. Nijman
MLMaria C. Lecca
Maria C. Lecca
LVLouis Vermeulen
Louis Vermeulen

1 November 2021 in Cell Stem Cell
Verified
Journal Article
Open access
SLSophie C. Lodestijn
Sophie C. Lodestijn
TBTom van Den Bosch
Tom van Den Bosch
LNLisanne E. Nijman
Lisanne E. Nijman
LMLeandro F. Moreno
Leandro F. Moreno
SSSophie Schlingemann
Sophie Schlingemann
LVLouis Vermeulen
Louis Vermeulen
The tissue dynamics that govern maintenance and regeneration of the pancreas remain largely unknown. In particular, the presence and nature of a cellular hierarchy remains a topic of debate. Previous lineage tracing strategies in the pancreas relied on specific marker genes for clonal labeling, which left other populations untested and failed to account for potential widespread phenotypical plasticity. Here we employed a tracing system that depends on replication-induced clonal marks. We found that, in homeostasis, steady acinar replacement events characterize tissue dynamics, to which all acinar cells have an equal ability to contribute. Similarly, regeneration following pancreatitis was best characterized by an acinar self-replication model because no evidence of a cellular hierarchy was detected. In particular, rapid regeneration in the pancreas was found to be driven by an accelerated rate of acinar fission-like events. These results provide a comprehensive and quantitative model of cell dynamics in the exocrine pancreas.

1 October 2021 in Cell Reports
Verified
Journal Article
Open access
SLSophie C. Lodestijn
Sophie C. Lodestijn
DMDaniël M. Miedema
Daniël M. Miedema
KLKristiaan J. Lenos
Kristiaan J. Lenos
LNLisanne E. Nijman
Lisanne E. Nijman
SBSaskia C. Belt
Saskia C. Belt
LVLouis Vermeulen
Louis Vermeulen
Effective treatments for pancreatic ductal adenocarcinoma (PDAC) are lacking, and targeted agents have demonstrated limited efficacy. It has been speculated that a rare population of cancer stem cells (CSCs) drives growth, therapy resistance, and rapid metastatic progression in PDAC. These CSCs demonstrate high clonogenicity in vitro and tumorigenic potential in vivo. However, their relevance in established PDAC tissue has not been determined. Here, we use marker-independent stochastic clonal labeling, combined with quantitative modeling of tumor expansion, to uncover PDAC tissue growth dynamics. We find that in contrast to the CSC model, all PDAC cells display clonogenic potential in situ. Furthermore, the proximity to activated cancer-associated fibroblasts determines tumor cell clonogenicity. This means that the microenvironment is dominant in defining the clonogenic activity of PDAC cells. Indeed, manipulating the stroma by Hedgehog pathway inhibition alters the tumor growth mode, revealing that tumor-stroma crosstalk shapes tumor growth dynamics and clonal architecture.

2 November 2022 in EMBO Molecular Medicine
Verified
Journal Article
Open access
SNSanne M van Neerven
Sanne M van Neerven
WSWouter L Smit
Wouter L Smit
MDMilou S van Driel
Milou S van Driel
VKVaishali Kakkar
Vaishali Kakkar
NGNina E de Groot
Nina E de Groot
LVLouis Vermeulen
Louis Vermeulen
The majority of colorectal cancers (CRCs) present with early mutations in tumor suppressor gene APC. APC mutations result in oncogenic activation of the Wnt pathway, which is associated with hyperproliferation, cytoskeletal remodeling, and a global increase in mRNA translation. To compensate for the increased biosynthetic demand, cancer cells critically depend on protein chaperones to maintain proteostasis, although their function in CRC remains largely unexplored. In order to investigate the role of molecular chaperones in driving CRC initiation, we captured the transcriptomic profiles of murine wild type and Apc‐mutant organoids during active transformation. We discovered a strong transcriptional upregulation of Hspb1, which encodes small heat shock protein 25 (HSP25). We reveal an indispensable role for HSP25 in facilitating Apc‐driven transformation, using both in vitro organoid cultures and mouse models, and demonstrate that chemical inhibition of HSP25 using brivudine reduces the development of premalignant adenomas. These findings uncover a hitherto unknown vulnerability in intestinal transformation that could be exploited for the development of chemopreventive strategies in high‐risk individuals.